Literature DB >> 30119176

Photodynamic therapy - mechanisms, photosensitizers and combinations.

Stanisław Kwiatkowski1, Bartosz Knap2, Dawid Przystupski1, Jolanta Saczko3, Ewa Kędzierska2, Karolina Knap-Czop4, Jolanta Kotlińska2, Olga Michel5, Krzysztof Kotowski1, Julita Kulbacka6.   

Abstract

Photodynamic therapy (PDT) is a modern and non-invasive form of therapy, used in the treatment of non-oncological diseases as well as cancers of various types and locations. It is based on the local or systemic application of a photosensitive compound - the photosensitizer, which is accumulated in pathological tissues. The photosensitizer molecules absorb the light of the appropriate wavelength, initiating the activation processes leading to the selective destruction of the inappropriate cells. The photocytotoxic reactions occur only within the pathological tissues, in the area of photosensitizer distribution, enabling selective destruction. Over the last decade, a significant acceleration in the development of nanotechnology has been observed. The combination of photosensitizers with nanomaterials can improve the photodynamic therapy efficiency and eliminate its side effects as well. The use of nanoparticles enables achievement a targeted method which is focused on specific receptors, and, as a result, increases the selectivity of the photodynamic therapy. The object of this review is the anticancer application of PDT, its advantages and possible modifications to potentiate its effects.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer therapy; PDT modification; Photodynamic therapy; Photosensitizers

Mesh:

Substances:

Year:  2018        PMID: 30119176     DOI: 10.1016/j.biopha.2018.07.049

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  196 in total

1.  Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers.

Authors:  Kelly A D F Castro; Letícia D Costa; Samuel Guieu; Juliana C Biazzotto; Maria Graça P M S da Neves; M Amparo F Faustino; Roberto S da Silva; Augusto C Tomé
Journal:  Photochem Photobiol Sci       Date:  2020-06-17       Impact factor: 3.982

2.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

Review 3.  Detection, identification, and quantification of oxidative protein modifications.

Authors:  Clare L Hawkins; Michael J Davies
Journal:  J Biol Chem       Date:  2019-10-31       Impact factor: 5.157

Review 4.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

5.  Highly Efficient Water-Soluble Photosensitizer Based on Chlorin: Synthesis, Characterization, and Evaluation for Photodynamic Therapy.

Authors:  Yue Sun; Xiaorui Geng; Yihui Wang; Xiaomin Su; Ruyin Han; Jiangyue Wang; Xinyan Li; Pan Wang; Kun Zhang; Xiaobing Wang
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-04

6.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

Review 7.  Targeting drug delivery with light: A highly focused approach.

Authors:  Teresa L Rapp; Cole A DeForest
Journal:  Adv Drug Deliv Rev       Date:  2021-01-22       Impact factor: 15.470

Review 8.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

9.  pH-Responsive Pluronic F127-Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer.

Authors:  Jingjing Zong; Hao Peng; Xin Qing; Zhe Fan; Wenjing Xu; Xuanlong Du; Ruihua Shi; Yewei Zhang
Journal:  ACS Omega       Date:  2021-04-30

10.  Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy.

Authors:  Zahra Arshadi; Sayedeh Azimeh Hosseini; Daryoush Fatehi; Seyed Abbas Mirzaei; Fatemeh Elahian
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.